Europe
Many non-vegan vegetarians and omnivores are open to including insects in their diet. For vegans, however, that is not an option, a new study from the University of Eastern Finland shows.
Company Is Committed to Leading Evidence Generation Across the Lung Cancer Care Continuum
Phage therapy could offer an alternative treatment method in the fight against antimicrobial resistance
Article provides full data set of pivotal clinical trial showing that HEMOBLAST Bellows is clinically and statistically superior to control at achieving hemostasis
Immunicum AB announced the composition of the Nomination Committee on 19 October 2018.
Lonza announced that Richard Ridinger, CEO, has decided to retire from the company after seven successful years.
Lonza reported a 9% organic sales, 12% organic CORE EBITDA and 14% organic CORE EBIT growth.
It’s no secret that the global biopharma and life sciences industry is large. Sometimes the immense size of the industry can lead fascinating news tidbits to fall through the cracks, particularly those from smaller companies scattered across the globe. This week BioSpace will launch a new roundup of news from companies across the globe.
Novartis Chief Executive Officer Vas Narasimhan said 2018 was a year of reimagining for Switzerland-based Novartis. It was a year when the company focused its capital and resourced on developing breakthrough medicines.
Karolinska Development’s portfolio company Umecrine Cognition announces overall results from a phase 2a study with the candidate drug GR3027 in patients with idiopathic hypersomnia.
PRESS RELEASES